Invited Lectures

Invited lecture at Pacifichem conference in symposia entitled Alternative Anti-infectives: Harnessing Chemistry to Evolve Drugs and Biological Molecules to Fight Against the 'Silent' Pandemic Honolulu, Hawaii, USA, 15-20 December 2025.

Invited closing Keynote lecture at the American Society for Tropical Medicine & Hygiene (ASTMH), Toronto, Canada, 9-13 November 2025.

Invited lecture at the ACS Global Conference, IIT Bombay, Mumbai, India, 8-11 October 2025.

The Global Health and Development Summit, 2025 Pujiang Innovation Forum, 22 September 2025.

Invited Plenary lecture at the International Symposium on Synthesis and Catalysis 2025 (ISySyCat25), University of Coimbra, Coimbra, Portugal, 2-5 September 2025

GHIT Invitation to attend 9th Tokyo International Conference on African Development (TICAD) and visit Eisai for a meeting, 20-22 August 2025.

Invited Closing Keynote lecture at the 66th London International Youth Science Forum (LIYSF), London, UK, 5 August 2025.

Invited Plenary lecture at the 59th Conference on Medicinal Chemistry (RICT 2025), Orléans, France, 2-4 July 2025.

Invited Opening Keynote lecture at the Malaria Gordon Research Conference, Barcelona, Spain, 25-30 May 2025.

Invited Opening Keynote lecture at the 3rd Commonwealth Chemistry Congress, Stellenbosch, South Africa, 11 May 2025.

Invited Opening Keynote lectures at the at the Molecular Sciences for Medicine (MoSMed) Annual conference, Durham University, Durham, UK, 15th-16th April 2025.

Invited keynote lecture in the session “Addressing Unmet Needs on Emerging and Re-Emerging Infectious Diseases” at the European Federation for Medicinal Chemistry and Chemical Biology (EFMC), XXVIII International Symposium of Medicinal Chemistry (EFMC-ISMC 2024), Rome, Italy 1-5 September 2024.

First Plenary Lecture at the 65th London International Youth Science Forum on Thursday 25 July 2024, London, UK.

2024 Durham Lecturer: University, UK, 3-7 June 2024.

Invited State-of-the-Art Speaker at the 125th Annual meeting of the American Society for Clinical Pharmacology and Therapeutics (ASCPT), The Broadmoor, Colorado Springs, Colorado, USA, 27-29 March, 2024.

Invited lecture at the 7th Molecular Approaches to Malaria (MAM) Conference, Lorne, Victoria, Australia, 18-22nd February, 2024.

Invited Lecture, European Laboratory Research & Innovation Group (ELRIG) - Drug Discovery 2023 – Diverse thinking – New Perspectives, Liverpool Exhibition Centre, Liverpool, United Kingdom, 18-19 October 2023.

Invited Lecture at the National Meeting of the Medicinal Chemistry Division of the Italian Chemical Society, 17-20 September 2023, Chieti close to the Adriatic Sea, Italy.

Invited Speaker at the Sir Howard Dalton Centre Day, 22 September 2023, IBRB, School of Life Sciences, University of Warwick, UK. "Work performed at H3D and the challenges faced and demonstration of how an understanding of enzymology can help in translational discovery".

Invited speaker at the 2023 Meeting of Tuberculosis Drug Discovery and Development Seminar, Barcelona, Spain, 22-23 July 2023."Researchers to present their work, discuss new methods, cutting edge idea and pre-published data".

Invited Lecture at the the 23rd Tetrahedron Symposium in Gothenburg, Sweden, 27-30 June 2023. 

Invited Speaker at an ACS Publications Symposium." Biological/ Medicinal Chemistry Research". University of Bonn in Germany. 6-8 March 2023.

Invited Speaker at the Hybrid HIPS Talk as a speaker at the Helmholtz - Institute for Pharmaceutical Research in Saarland, Saarbrucken. "Mycobacterium Tuberculosis - Mediated Drug Metabolism Friend and Foe?". 2-4 March 2023.

Atlantic Basin Conference on Chemistry (ABCChem). Chemistry and Biology & Health plenary lecture, Marrakech, Morocco, 13-16 December 2022.

Invited Lecture in Brussels,Beerse at Johnson & Johnson 24 November 2022. Topic: 'Small molecule drug discovery to combat drug-resistant infections".

Invited Lecture in Brussels, Belgium at the European Commission. Pre-clinical research of broad-spectrum antivirals and present the work of H3D, 21-23 November 2022.

4th Annual meeting of the Crick African Network (CAN), Vineyard Hotel, Cape Town. Closing Keynote Lecture. Hosted by UCT and Stellenbosch University, 6-10 December 2022. Showcasing research and the translational approach taken in building H3D into a pathbreaking organization. Talks about Malaria, TB and AMR.

Global Health Drug Discovery in Africa: Challenges and Opportunities.. Invited Commemorative Fund Lecture at the American Society of Tropical Medicine and Hygiene (ASTMH), 2018 Annual Meeting at the Sheraton, New Orleans, October 30, 2018. This lecture—one of the Society’s most prestigious—is by invitation only from the President of ASTMH on behalf of the Council of ASTMH to a highly accomplished researcher from the tropics

Confronting Afro-pessimism. Invited Spotlight Talk at the 2018 Grand Challenges Meeting, Joint Plenary: Keystone Symposia: Innovation in Drug Discovery 18th October 2018, Berlin, Germany.

Innovation in health R&D – in Africa, for Africa. Invited Keynote Lecture at the Drug for Neglected Diseases initiative (DNDi) Partners meeting, Kampala, Uganda, 04 October 2018

PI4K inhibitors that target multiple life cycle stages of the human malaria parasite.  Invited Lecture at the 19th Royal Society of Chemistry (RSC / Society of Chemical Industries (SCI) Medicinal Chemistry Symposium, 10th-13th September 2017, Churchill College, University of Cambridge, UK

Accelerating sustainable pharmaceutical Research and Development in Africa. Invited Keynote Lecture at Planet Earth Institute (PEI) #ScienceAfrica UnConference “Big Ideas for Africa: Celebrating the Continent’s Science and Technology Pioneers”. London, UK, 20 July 2017

Next generation PI4K inhibitors that impact the entire parasite life cycle. Invited lecture at the XIX International Congress for Tropical Medicine and Malaria (ICTMM), 18-22 September 2016, Brisbane, Australia.

Recent Drug Discovery case histories for malaria. Invited lecture at the Canada Malaria Symposium, Science and policy shield the vulnerable from malaria, 20 June, 2016, McGill University, Montreal, Canada.

Antimalarials from SoftFocus Libraries: Optimization and Target Identification. Invited lecture at the Keystone Symposium, Drug Discovery for Parasitic Diseases, 24-29 January, 2016, Granlibakken Resort, Tahoe City, California, USA.

African-Led Health Innovation to Tackle Global Health Challenges through Partnerships: The H3D Example. Invited Lecture at the 9th European Congress on Tropical Medicine and International Health (ECTMIH) as part of GHIT Symposium “The Japanese contribution to tackle global”, 6-10 September 2015, Basel, Switzerland

The 1st Small Molecule Clinical Candidate Discovered in Africa. Invited Lecture at the American Chemical Society (ACS) symposium entitled "New Models for Drug Discovery', 249th ACS National Meeting in Denver, Colorado, March 22nd – 25th, 2015, USA.

Medicinal chemistry progression of phenotypic HTS hits for TB from SoftFocus libraries. Invited lecture at the Gordon Conference on Tuberculosis (TB) Drug Development, 21-26 July 2013, Lucca, Barga, Italy. Under session “Compounds”.  .

Hit to Lead and Lead Optimization of Antimalarial and Antituberculosis Whole Cell Hits from a SoftFocus Library. Invited Lecture at the American Chemical Society (ACS)  symposium entitled "Challenges in Phenotypic Whole Cell High throughput Screening and Medicinal Chemistry Optimization of Hits; Strategies to Discover Novel Antiparasitic and Antimycobacterial Agents", 243rd ACS National Meeting 25-29 March 2012, San Diego, California, USA. 

Chemical Approaches to the Reversal of Chloroquine Resistance in the Malaria Parasite Plasmodium falciparum. Invited Keynote Lecture at the 7th Asian International Medicinal Chemistry (AIMECS09) Congress, Cairns, Australia, 23-27 August 2009.

Privileged Structures and Multi-Component Reaction Strategies in Antiprotozoal Drug Discovery.  Invited lecture at the Keystone Symposia, Drugs Against Protozoan Parasites, 28 Jan-1 February 2007, Lake Tahoe, Tahoe City, California, USA.

Pharmacophore for the Rational Design of Chemosensitizers Against Drug Resistant Malaria Parasites.  Invited lecture at the American Chemical Society-Council for Scientific and Industrial Research (India) conference on Advances in Organic Chemistry and Chemical Biology (AOCCB), 11-12 Jan 2006, Indian Institute of Chemical Technology (IICT), Hyderabad, India.

Acetolactate Synthase Inhibitors as Novel Anti-tuberculosis Agents. Plenary lecture at the Gordon Conference on Tuberculosis (TB) Drug Development, 31 Aug -5 Sept 2003, Queens’ College, University of Oxford, UK.